A major advance in cancer investigation is arising with the use of nanobodies to re-engage dysfunctional p53. This essential cancer protector protein is frequently inactivated in several kinds of tumors, causing https://get-social-now.com/story7423613/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-hope-for-malignant-management